Will Colgate Spin Off Pet Food Biz? This Hedge Fund Hopes So, Plus 2 Dividend Stocks It Trades
Activist investor Dan Loeb recently aired, and retracted, his statements on whether Walt Disney Co. (NYSE: DIS) should spin off ESPN.
Verizon Business To Launch Multi-Session, Multi-Day Events With BlueJeans Expo
What you need to know:
New all-in-one event management platform delivers fully customizable virtual experiences to transform virtual events into a Community Hub.
NEW YORK, Oct. 19, 2022 (GLOBE
Enanta Pharmaceuticals Presents New Preclinical Data For EDP-235, Its Oral, Direct-Acting Antiviral Protease Inhibitor Specifically Designed For The Treatment Of COVID-19 At IDWeek 2022 On October 21
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced new preclinical data supporting
Recession Is Imminent, This Wells Fargo Exec Says: How To Navigate The Bear Market Rally
Chris Harvey, head of equity strategy for Wells Fargo & Co.
Caribou Biosciences Presents Case Report On Long-Term Follow Up Of First Patient Dosed In Phase 1 ANTLER Trial At The Lymphoma, Leukemia, & Myeloma Congress 2022 October 18-22
Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the presentation of a case report for long-term follow up on the first patient
Design Therapeutics To Present Preclinical Data Highlighting The Potential Of Its GeneTAC Small Molecule, DT-216, For The Treatment Of Friedreich Ataxia At International Congress for Ataxia Research 2022 November 3
Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that preclinical data for the company's novel
Tesla Shares Have A Supporter in Congress: House Rep. McKinley Also Likes These 2 Dividend Stocks
Republican Congressman David McKinley recently purchased $1,000 to $15,000 shares in Tesla (NASDAQ: TSLA) for a price of $300.80 per share, in an undisclosed position, per Capito
Merger Monday Vindicated This Analyst Who Nailed BP’s Offer Price As Energy M&A Heats Up
On Oct. 4, Wells Fargo & Co. (NYSE: WFC) analyst Michael Blum initiated coverage of Archaea Energy Inc.
BridgeBio Pharma Highlights Its RAS Precision Oncology Portfolio And Shares Compelling Data From Next-Generation G12C Inhibitor And Novel PI3Kα:RAS Breaker Mechanism At The Fourth RAS Initiative Symposium
- BridgeBio to host investor call today (October 17, 2022) at 1:30 pm ET to discuss its two most advanced RAS precision oncology programs – KRASG12C GTP/GDP dual inhibitor development candidate
Anavex Life Sciences Announces Late-Breaking Presentation Of Phase 2b/3 Data of Oral ANAVEX 2-73 (blarcamesine) For Early Alzheimer’s Disease At Upcoming Clinical Trials On Alzheimer’s Disease (CTAD) Congress 2022
Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and